A. Uldam

Pharmacological and behavioral profile of ACP-103, a novel 5-HT 2A receptor inverse agonist

Robert I. Davis, M. Geyer, D. Weiner, 2006 .

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Ethan S. Burstein, Fabrice Piu, Mark R. Brann, 2006, Journal of Pharmacology and Experimental Therapeutics.

Exploring the potential for subtype-selective muscarinic agonists in glaucoma.

M. Brann, T. Spalding, E. Woldemussie, 2001, Life sciences.